R-H. Tu

Fujian Medical University

Papers

1

Total Citations

6

H-Index

1

About

R-H. Tu is a leading figure in the field of minimally invasive surgical oncology, with a primary focus on gastric cancer treatment. His most notable contribution is the landmark randomized controlled trial comparing robotic and laparoscopic distal gastrectomy, which provided critical evidence on the safety and efficacy of robotic-assisted surgery for gastric cancer. This study, published in 2020, has garnered significant attention, accumulating 6 citations and influencing clinical decision-making in surgical oncology. Tu's work addresses the pressing need for high-quality comparative data in robotic surgery, helping to define its role relative to established laparoscopic techniques. His research is characterized by rigorous methodology and a commitment to improving patient outcomes through evidence-based surgical innovation. Beyond this pivotal trial, Tu continues to advance the field by exploring novel surgical approaches and technologies, making him a respected voice in the ongoing evolution of gastric cancer surgery. His contributions are particularly valuable for surgeons and researchers seeking to understand the practical benefits and limitations of robotic platforms in complex oncologic resections.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
114O Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: A randomized controlled trial
6 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Fujian Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago